Last updated: 2026-09-09 05:11:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
RadNet, Inc. (RDNT) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $71.97, with a market capitalization of $5.80B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $50.82 to $85.84. This page covers its latest market performance, valuation, price trends and company information.
$5.80B | |
$72.72 | |
$93.65 | |
$0.85 | |
$73.71 | |
298.04K | |
821.69K | |
-- | |
$85.84 | |
$50.82 | |
-- | |
-- |
RadNet, Inc. (RDNT) last closed at $73.71 as of 2026-09-08 23:31:00, unchanged from the previous close of $73.71.
During the latest regular trading session, RDNT traded between $0.85 and $93.65, with a volume of 298.04K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, RadNet, Inc. (RDNT) moved from $75.36 to $71.97, representing a decline of 4.50% ($3.39).
The stock traded between $71.81 and $76.97 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 682.86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 60.4%
RDNT is currently trading at $71.97, placing it 60.4% of the way from its 52-week low of $50.82 to its 52-week high of $85.84. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 11264 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of RadNet, Inc. (RDNT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.